COVID-19

Community-onset bacterial coinfection in children critically ill with SARS-CoV-2 infection |
Risk of Coronavirus Disease 2019–Associated Pulmonary Aspergillosis Based on Corticosteroid Duration |
Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection | Long-term gastrointestinal outcomes of COVID-19 | Confronting the evolution and expansion of anti-vaccine activism in the USA |
Effectiveness of Maternal Influenza Vaccination in Peru PRIME Cohort |
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland | Immunomodulators for severe coronavirus disease-2019 in transplant patients | Characteristics and predictors of persistent symptoms post-COVID-19 in children and young people | Parental Nonadherence to Health Policy Recommendations for Prevention of COVID-19 | Viral kinetics of sequential SARS-CoV-2 infections |
Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population | One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition

Fatal Fulminant Cerebral Edema in Six Children With SARS-CoV-2 Omicron BA.2 Infection in Taiwan |
Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children |
COVID-19 vaccines versus pediatric hospitalization | Maternal SARS-CoV-2 vaccination and infant protection against SARS-CoV-2 | Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children |
Efficacy of first dose of covid-19 vaccine versus no vaccination on symptoms of patients with long covid | Effect of covid-19 vaccination on long covid: systematic review |
FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses |
Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 | Certifying Deaths Due to Coronavirus Disease 2019

Sex differences in cardiovascular complications and mortality in hospital patients with covid-19 |
Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults | A third vaccine dose equalizes the levels of effectiveness | Sotrovimab retains activity against SARS-CoV-2 Omicron variant | Effect of Higher-Dose Ivermectin for 6 Days vs Placebo on Time to Sustained Recovery in Outpatients | Viral burden rebound in hospitalized patients with COVID-19 receiving oral antivirals | Serological response to vaccination in post-acute sequelae of COVID | Association of COVID-19 Vaccination With Risk for Incident Diabetes After COVID-19 Infection | Past SARS-CoV-2 infection protection against re-infection | Postacute Sequelae of SARS-CoV-2 in University Setting

The Negative Effect of Preexisting Immunity on Influenza Vaccine |
Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells |
Bacillus Calmette-Guérin vaccine for prevention of COVID-19 and other respiratory tract infections in older adults | Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection | Early Treatment with Pegylated Interferon Lambda for Covid-19 | Long-term high-dose immunoglobulin successfully treats Long COVID patients with pulmonary, neurologic, and cardiologic symptoms |
Consistency of covid-19 trial preprints with published reports |
Peru confirms H5N1 avian flu in marine mammals | Incidence of Chronic Spontaneous Urticaria |
COVID-19 Mortality and Progress Toward Vaccinating Older Adults

Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection | Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods | Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients | Effectiveness of Bivalent Boosters against Severe Omicron Infection |
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus versus Influenza in Adults | Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US |
Association of culturable-virus detection and household transmission of SARS-CoV-2 – California and Tennessee, 2020–2022 | Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients

Codetections of Other Respiratory Viruses Among Children Hospitalized With COVID-19 |
Early and Increased Influenza Activity Among Children — Tennessee |
SARS-CoV-2 variant-related abnormalities detected by prenatal MRI | COVID-19 vaccines versus pediatric hospitalization |
Persistent COVID-19 Symptoms at 6 Months After Onset | Effects of Dexamethasone Use on Viral Clearance Among Patients with COVID-19: A Multicenter Cohort Study |
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases |
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant

Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study | Effectiveness of the Bivalent mRNA Vaccine in Preventing Severe COVID-19 Outcomes: An Observational Cohort Study | 7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection | Increasing Ventilation Reduces Sars-Cov-2 Airborne Transmission In Schools | Use of Carbon Dioxide Monitoring to Assess Ventilation at a National Infectious Diseases Conference

Virological characteristics of the SARS-CoV-2 XBB variant | SARS-CoV-2 infection and persistence in the human body | Long-term cardiovascular outcomes of COVID-19 | Heart-disease risk soars | Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants | Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines |
Time to negative PCR conversion among high-risk patients | The Fc-effector function of COVID-19 convalescent plasma | Infectiousness of SARS-CoV-2 breakthrough infections and reinfections